OSEBX1 945,09+0,00 %
EQNR349,90+0,00 %
DNB281,10+0,00 %
MOWI202,20+0,00 %
Brent$102,00+0,72 %
Gold$4 714,90+0,44 %
USD/NOK9,3028+0,03 %
EUR/NOK10,9325+0,06 %
SPX7 365,12+1,46 %
NDX28 599,17+2,08 %
MARKETS CLOSED · LAST TRADE Thu 03:12 UTC
BIOF.PK56

Blue Biofuels Inc

Renewable FuelsVerified
Score breakdown
Sentiment+27Risk penalty-3Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion97AI synthesis40Observations3

Blue Biofuels has a negative equity position of -$3.7 million and a debt-to-equity ratio of -0.5, indicating a leveraged capital structure with liabilities exceeding assets [doc:HA-latest]. The company's liquidity is constrained, with a current ratio of 0.03 and only $65,200 in cash and equivalents, which is insufficient to cover short-term obligations [doc:HA-latest]. The negative free cash flow of -$2.9 million and operating cash flow of -$845,000 further highlight the company's cash flow challenges [doc:HA-latest]. Profitability metrics are weak, with a net loss of -$2.88 million and an operating loss of -$3.72 million in the latest period [doc:HA-latest]. The return on assets (ROA) is -2.04%, and the return on equity (ROE) is 77.56%, which is misleading due to the negative equity base [doc:HA-latest]. These figures fall significantly below the industry median for renewable fuels, where positive ROA and ROE are typically expected for operational viability [doc:industry_config]. The company's revenue is reported as $0, and there is no disclosed geographic or segment breakdown in the financial data, making it difficult to assess revenue concentration or diversification [doc:HA-latest]. The absence of segment data limits the ability to evaluate the performance of its CTS and vertimass technologies separately [doc:HA-latest]. Outlook data is not available for the current or next fiscal year, but the historical financial performance suggests a lack of revenue generation and ongoing losses [doc:HA-latest]. The company has not demonstrated a path to profitability or positive cash flow, which raises concerns about its long-term viability [doc:HA-latest]. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the key flag of negative net cash after subtracting total debt highlights the company's financial instability [doc:HA-latest]. The negative equity and high leverage increase the risk of insolvency, and the lack of positive cash flow suggests a need for external financing, which could lead to further dilution or debt accumulation [doc:HA-latest]. Recent filings and transcripts are not provided in the input data, so no specific events can be cited to explain the company's financial condition [doc:HA-latest]. However, the absence of revenue and the ongoing losses suggest that the company is in the early stages of commercialization or facing operational challenges [doc:HA-latest].

30-day price · BIOF.PK+0.01 (+5.0%)
Low$0.12High$0.16Close$0.16As of6 May, 00:00 UTC
Profile
CompanyBlue Biofuels Inc
TickerBIOF.PK
SectorEnergy
BusinessRenewable Energy
Industry groupRenewable Energy
IndustryRenewable Fuels
AI analysis

Business. Blue Biofuels Inc develops and commercializes technologies for converting cellulose into biofuels and lignin, including its Cellulose-to-Sugar (CTS) and vertimass processes, which produce cellulosic ethanol, sustainable aviation fuel, and other renewable fuels [doc:HA-latest].

Classification. Blue Biofuels is classified in the Energy sector under Renewable Energy, specifically in the Renewable Fuels industry, with a confidence level of 0.92 [doc:verified market data].

Blue Biofuels has a negative equity position of -$3.7 million and a debt-to-equity ratio of -0.5, indicating a leveraged capital structure with liabilities exceeding assets [doc:HA-latest]. The company's liquidity is constrained, with a current ratio of 0.03 and only $65,200 in cash and equivalents, which is insufficient to cover short-term obligations [doc:HA-latest]. The negative free cash flow of -$2.9 million and operating cash flow of -$845,000 further highlight the company's cash flow challenges [doc:HA-latest]. Profitability metrics are weak, with a net loss of -$2.88 million and an operating loss of -$3.72 million in the latest period [doc:HA-latest]. The return on assets (ROA) is -2.04%, and the return on equity (ROE) is 77.56%, which is misleading due to the negative equity base [doc:HA-latest]. These figures fall significantly below the industry median for renewable fuels, where positive ROA and ROE are typically expected for operational viability [doc:industry_config]. The company's revenue is reported as $0, and there is no disclosed geographic or segment breakdown in the financial data, making it difficult to assess revenue concentration or diversification [doc:HA-latest]. The absence of segment data limits the ability to evaluate the performance of its CTS and vertimass technologies separately [doc:HA-latest]. Outlook data is not available for the current or next fiscal year, but the historical financial performance suggests a lack of revenue generation and ongoing losses [doc:HA-latest]. The company has not demonstrated a path to profitability or positive cash flow, which raises concerns about its long-term viability [doc:HA-latest]. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the key flag of negative net cash after subtracting total debt highlights the company's financial instability [doc:HA-latest]. The negative equity and high leverage increase the risk of insolvency, and the lack of positive cash flow suggests a need for external financing, which could lead to further dilution or debt accumulation [doc:HA-latest]. Recent filings and transcripts are not provided in the input data, so no specific events can be cited to explain the company's financial condition [doc:HA-latest]. However, the absence of revenue and the ongoing losses suggest that the company is in the early stages of commercialization or facing operational challenges [doc:HA-latest].
Key takeaways
  • Blue Biofuels has a negative equity position and a debt-to-equity ratio of -0.5, indicating a highly leveraged capital structure.
  • The company reported a net loss of -$2.88 million and an operating loss of -$3.72 million, with no revenue in the latest period.
  • Liquidity is critically low, with a current ratio of 0.03 and only $65,200 in cash and equivalents.
  • The company has not disclosed segment or geographic revenue data, limiting visibility into its business performance.
  • The risk assessment highlights a medium liquidity risk and a key flag of negative net cash after subtracting total debt.
  • The absence of revenue and ongoing losses suggest the company is in the early stages of commercialization or facing operational challenges.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$0.00
Gross profit
Operating income-$3.7M
Net income-$2.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$845.0k
CapEx-$137.3k
Free cash flow-$2.9M
Total assets$1.4M
Total liabilities$5.1M
Total equity-$3.7M
Cash & equivalents$65.2k
Long-term debt$1.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$3.7M
Net cash-$1.8M
Current ratio0.0
Debt/Equity-0.5
ROA-2.0%
ROE77.6%
Cash conversion29.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Renewable Energy · cohort 99 companies
MetricBIOF.PKActivity
Op margin1.8% medp25 -56.6% · p75 10.9%
Net margin-2.0% medp25 -60.9% · p75 6.5%
Gross margin19.3% medp25 7.6% · p75 33.8%
CapEx / revenue-6.2% medp25 -23.3% · p75 -1.3%
Debt / equity-50.0%25.9% medp25 4.4% · p75 73.8%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 07:32 UTC#2db03dc6
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 07:34 UTCJob: 8c9aa1e6